Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Curent Deferred Tax Liability: 2014

Historic Curent Deferred Tax Liability for Amphastar Pharmaceuticals (AMPH) over the last 1 years, with Dec 2014 value amounting to $1.2 million.

  • Amphastar Pharmaceuticals' Curent Deferred Tax Liability fell 79.80% to $161,000 in Q3 2015 from the same period last year, while for Sep 2015 it was $161,000, marking a year-over-year decrease of 79.80%. This contributed to the annual value of $1.2 million for FY2014, which is N/A change from last year.
  • According to the latest figures from FY2014, Amphastar Pharmaceuticals' Curent Deferred Tax Liability is $1.2 million.
  • Over the past 5 years, Amphastar Pharmaceuticals' Curent Deferred Tax Liability peaked at $1.2 million during FY2014, and registered a low of $1.2 million during FY2014.
  • Moreover, its 1-year median value for Curent Deferred Tax Liability was $1.2 million (2014), whereas its average is $1.2 million.